Vancomycin Utilization Evaluation at Hematology-Oncology Ward of a Teaching Hospital in Iran

被引:0
|
作者
Vazin, Afsaneh [2 ]
Japoni, Aziz [3 ]
Shahbazi, Sakineh [2 ]
Davarpanah, Mohammad Ali [1 ]
机构
[1] Shiraz Univ Med Sci, Shiraz HIV AIDS Res Ctr, Internal Med Ward, Shiraz, Iran
[2] Shiraz Univ Med Sci, Pharmaceut Res Ctr, Dept Clin Pharm, Fac Pharm, Shiraz, Iran
[3] Shiraz Univ Med Sci, Nemazee Hosp, Prof Alborzi Clin Microbiol Res Ctr, Shiraz, Iran
来源
关键词
Vancomycin; Drug utilization research; Appropriate drug use; Serum concentration; RESISTANT ENTEROCOCCUS-FAECIUM; RANDOMIZED CONTROLLED-TRIALS; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS; NEUTROPENIC PATIENTS; FEBRILE NEUTROPENIA; GLYCOPEPTIDE USE; OUTBREAK; THERAPY; METAANALYSIS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to evaluate the pattern of vancomycin administration in the hematology-oncology ward of Nemazee Hospital, Shiraz, Iran. Study criteria were developed to assess the several parameters involved in vancomycin therapy. These parameters include the appropriateness of drug usage, dosage, duration of therapy, monitoring for toxicity and serum concentration monitoring. The serum concentration was measured by an automated Fluorescence Polarization Immunoassay. Clinical and preclinical parameters such as Glomerular Filtration Rate (GFR), microbial culture, antibacterial sensitivity, WBC count and fever were collected and recorded for analysis. Sixty patients were enrolled in the study, consisting of 45 males and 15 females. The age range was 15 to 68 years. In this study, 68.63% of the vancomycin used for the patients with febrile neutropenia was compatible with the Infectious Disease Society of America (IDSA) guideline. The initial dosage of vancomycin in 68.63%, rate of infusion in 100%, and dilution of vancomycin in 100%, were appropriate. Inappropriate use was more evident in the continuation of vancomycin in 50% of the patients. No appropriate dosage adjustment was done for 50% of the patients with increased serum creatinine. Based on the results, the indication of vancomycin in febrile neutropenia was satisfactory. However, there were some required factors such as continuation of vancomycin, adjustment of dosage or interval, microbial culture, antibiotic sensitivity test before the first dose administration, measurement of serum concentration and monitoring which had to be revised in order to achieve an effective treatment.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 50 条
  • [21] Drug Utilization Evaluation of Erythropoietin at a Referral Teaching Hospital in Iran
    Karimzadeh, Iman
    Rasekh, Hanieh
    Karimian, Ava
    Shabani-Borujeni, Mojtaba
    Vazin, Afsaneh
    ADVANCES IN PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES, 2023, 2023
  • [22] Evaluation of Inflammatory Biomarkers in Pediatric Hematology-Oncology Patients With Bloodstream Infection
    Chen, Senmin
    Liu, Sixi
    Yuan, Xiuli
    Wang, Huihui
    Wen, Feiqiu
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : E596 - E600
  • [23] Vancomycin utilization at a teaching hospital in Hong Kong
    You, JHS
    Lyon, DJ
    Lee, BSC
    Kwan, SM
    Tang, HY
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (22) : 2167 - 2169
  • [24] Improvement of vancomycin utilization in a community teaching hospital
    Gitman, Brenda
    Patel, Rani
    Varghese, Mini
    Patel, Sonia D.
    Philips, Ashmi A.
    Gugliotta, Joseph
    PHARMACOTHERAPY, 2012, 32 (10): : E271 - E271
  • [25] Evaluation of Continuous Infusion Vancomycin in a Pediatric Hematology/Oncology Population
    King, Madeleine A.
    Cross, Shane J.
    Morton, Theodore H.
    Hijano, Diego R.
    Greene, William L.
    Sun, Yilun
    Tang, Li
    Pauley, Jennifer L.
    Bourque, Melissa S.
    Christensen, Anthony M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (06) : 520 - 524
  • [26] The Utility of Interaction Design as a Novel Tool to Improve Hand Hygiene Frequency on a Pediatric Hematology-Oncology Ward
    Blaak, Johanna
    DiMaio, Rachel
    Kupis, Julia
    Sweetzir, Ross
    Betuzzi, Conny
    Dowler, Corey
    McIntytre, Krista
    Kaufman, Jaime
    Hallihan, Greg
    Conly, John
    Vayalumkal, Joseph
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S411 - S411
  • [27] Experience in the treatment of Gaucher disease with Imiglucerase in the Department of Pediatric Hematology-Oncology at the University Hospital
    Figueredo, Diego
    Zelada, Ofelia
    Servin, Jazmin
    Mattio, Isabel
    Samudio, Angelica
    PEDIATRIA-ASUNCION, 2015, 42 (02): : 115 - 119
  • [28] EVALUATION OF AN UPDATED PEDIATRIC EARLY WARNING SCORE IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS
    Imperiale, Brighid
    Beuerlein, Miranda
    Graef, Jessica
    Szeles, Rose
    Mallick, Nada
    Wistinghausen, Birte
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S187 - S187
  • [30] An outbreak of vancomycin-resistant enterococci in a hematology-oncology unit: Control by patient cohorting and terminal cleaning of the environment
    Sample, ML
    Gravel, D
    Oxley, C
    Toye, B
    Garber, G
    Ramotar, K
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (08): : 468 - 470